RBC Capital notes that Verastem (VSTM) has formalized its key strategic priorities and catalysts for 2025, which largely align with the firm’s ...
In a research report released Friday, Mr. Kornack adjusted his earnings expectations across the sector to reflect a higher ...
Financial writer discusses RBC Capital's bullish outlook on Carvana, citing upside potential in retail unit estimates and path to durable free cash flow.
However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...
Investing.com -- RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270. According to the firm’s analysts, following ...
Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital ...
A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...
Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...
Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...